|
|
Article: Nasal spray approved for treatment of allergies
- Article from:
- Drug Topics
- Article date:
- November 20, 2006
- Author:
CopyrightCopyright Advanstar Communications, Inc. Nov 20, 2006. Provided by ProQuest LLC. (Hide copyright information)
|
NEW DRUG
The Food & Drug Administration recently approved ciclesonide (Omnaris, Altana Pharma) for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and children 12 years and older.
Allergic rhinitis, or hay fever, affects more than 35 million Americans. Symptoms range from brief, infrequent episodes of runny nose and itchy, watery eyes to persistent, severe symptoms lasting more than four days a week that may lead to inability to sleep, chronic malaise, and poor work or school efficiency.
The therapeutic goal for patients is to minimize or prevent symptoms. Therapeutic modalities include allergen avoidance and pharmacologie management. ...